首页 › 基金 › HEIGHTS CAPITAL MANAGEMENT, INC › TSHA
HEIGHTS CAPITAL MANAGEMENT, INC 对 TSHA 的持仓历史
TAYSHA GENE THERAPIES INC · 医疗保健
HEIGHTS CAPITAL MANAGEMENT, INC 在 Q3 2026 的 13F 申报中披露持有 TSHA(TAYSHA GENE THERAPIES INC)1,375,760 股,市值约 US$6.7M,约占其申报组合的 1.66%,在其申报持仓中市值排名第 8 位。 HEIGHTS CAPITAL MANAGEMENT, INC 最近 2 个申报季度中有 2 个季度披露了 TSHA 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
HEIGHTS CAPITAL MANAGEMENT, INC 对 TSHA 的持仓演变
HEIGHTS CAPITAL MANAGEMENT, INC 于 Q2 2026 首次披露 TSHA 持仓:1,500,000 股(约 US$10.2M)。 在 2 次申报中,HEIGHTS CAPITAL MANAGEMENT, INC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,375,760 股、市值约 US$6.7M,环比减持 -124,240 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.50M | $10.21M | 新进 |
| Q3 2026 | 1.38M | $6.70M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TSHA 与 13F 数据
TSHA(TAYSHA GENE THERAPIES INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 TSHA,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$148.2M), Avoro Capital Advisors LLC (US$116.3M), Vestal Point Capital, LP (US$87.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TSHA 的基金
- RA CAPITAL MANAGEMENT, L.P. 30.44M 股 · $148.22M · Q3 2026
- Avoro Capital Advisors LLC 23.89M 股 · $116.34M · Q3 2026
- Vestal Point Capital, LP 18.05M 股 · $87.88M · Q3 2026
- RTW INVESTMENTS, LP 13.56M 股 · $66.04M · Q3 2026
- Siren, L.L.C. 9.85M 股 · $47.95M · Q3 2026
- Octagon Capital Advisors LP 9.69M 股 · $47.21M · Q3 2026
- MPM BioImpact LLC 7.26M 股 · $35.37M · Q3 2026
- BAKER BROS. ADVISORS LP 4.00M 股 · $19.50M · Q3 2026
- Casdin 资本 3.90M 股 · $18.99M · Q3 2026
- ADAR1 Capital Management, LLC 3.06M 股 · $14.90M · Q3 2026
- B Group, Inc. 1.80M 股 · $8.77M · Q3 2026
- Palo Alto Investors LP 1.34M 股 · $6.51M · Q3 2026
更多关于 HEIGHTS CAPITAL MANAGEMENT, INC
常见问题
How long has HEIGHTS CAPITAL MANAGEMENT, INC held TSHA?
HEIGHTS CAPITAL MANAGEMENT, INC has disclosed TSHA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is HEIGHTS CAPITAL MANAGEMENT, INC's current position in TSHA?
As of Q3 2026, HEIGHTS CAPITAL MANAGEMENT, INC holds 1.38M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $6.70M, representing 1.66% of its reported portfolio and ranking #8.
Has HEIGHTS CAPITAL MANAGEMENT, INC been buying or selling TSHA?
In the latest 13F filing (Q3 2026), HEIGHTS CAPITAL MANAGEMENT, INC reduced its position in TSHA.
Which other funds hold TSHA?
Other major institutional holders of TSHA include RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Vestal Point Capital, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.